期刊文献+

超声增强紫杉醇微泡剂对人卵巢癌COC1细胞增殖的抑制作用

Ultrasound Enhancing Inhibition of the Proliferation of Human Ovarian Cancer Cells COC1 by Paclitaxel Microbubbles
下载PDF
导出
摘要 目的探讨超声联合紫杉醇微泡剂对人卵巢癌细胞COC1的增殖抑制作用。方法将人卵巢癌细胞株COC1随机分为6组:对照组、空白微泡剂+超声组、紫杉醇微泡剂组、单纯紫杉醇组、紫杉醇+超声组、紫杉醇微泡剂+超声组。观察各组处理后癌细胞的增殖、细胞形态及细胞凋亡情况。结果紫杉醇微泡剂+超声组COC1细胞增殖被明显抑制,24,48,72 h的抑制率分别为(43.60±2.64)%,(37.89±1.30)%,(28.95±2.89)%。电镜观察结果显示,紫杉醇微泡剂+超声组的COC1细胞数量减少最显著(P<0.05),细胞折光度差,细胞固缩,出现许多细胞碎屑,PI/hoechst染色检测显示细胞凋亡率最高,为(52.67±9.29)%(P<0.05)。结论超声能有效增强紫杉醇微泡剂对人卵巢癌细胞COC1的杀伤能力。 Objective To determine inhibition of the proliferation of human ovarian cancer cells COCI by ultrasonic irradiation and paclitaxel-carrying microbubbles. Methods The cells were randomly divided into six groups: control group, blank microbubbles plus ultrasound, paclitaxel-carrying microbubbles, paclitaxel, paclitaxel plus ultrasound, and paclitaxel-carrying microbubbles plus ultrasound. The inhibitory effect of the cell growth was observed by the MTT assay, cell morphology and apoptosis rate were detected. Results The growth of COC1 cells were significantly suppressed by paclitaxel-carrying microbubbles plus ultrasound, the inhibitory rates of which were ( 43.60 ± 2.64 ) %, ( 37.89 ± 1.30 ) %, ( 28.95 ± 2.89 ) % at 24,48,72 h, respectively. The most significant cell number reduction was found in the group of paclitaxel-carrying microbubbles plus ultrasound(P 〈 0.05 ) and the decreased cell diopter, cell shrinkage and a lot of cell debris were observed as well. The apoptosis rate reached ( 52. 67 ± 9. 29 ) % by PI/hoechst staining assay ( P 〈 0. 05 ). Differences with other groups were significant. Conclusion Low-intensity focused ultrasound could effectively enhance inhibition of proliferation of human ovarian cancer cells COCI by paclitaxel-carrying microbubbles.
出处 《医药导报》 CAS 2009年第12期1551-1553,共3页 Herald of Medicine
关键词 紫杉醇 微泡剂 卵巢癌 超声 Paelitaxel Microbubble Ovarian caner Ultrasound
  • 相关文献

参考文献10

二级参考文献15

  • 1黄义昆.脂质体作为药物载体研究进展[J].中国药师,2005,8(7):549-550. 被引量:24
  • 2[1]Main ML, Grayburn PA. Clinical applications of transpulmonary contrast echocardiography. Am Heart J,1999,137(1):144-153.
  • 3[2]Luo H, Nishioka T, Fishbein MC, et al. Transcutaneous ultrasound augments lysis of arterial thrombi in vivo. Circulation, 1996,94(4):775-778.
  • 4[3]Feng R, Wang ZB. Practical Ultrasound. Beijing: Scientific and Technical Documents Publishing House,2002,234-236.
  • 5[4]Ward M, Wu J, Chiu JF. Experimental study of the effects of optison concentration on sonoporation in vitro. Ultrasound Med Biol,2000,26(7):1169-1175.
  • 6[5]Wu W, Ning XB, Jiang Z, et al. Formation of micro-vessel embolization in rabbit liver induced by low power ultrasound irradiation combined with LEVOVIST agent. J Southeast Univ (Nat Sci),2003,33(3):300-302.
  • 7[6]Jiang NY. Oncology Nuclear Medicine. Beijing: People's Medical Publishing House,2002.1-20.
  • 8[7]Wang RF. Nuclear Medicine[M]. Beijing: Peking Univ Med Press,2004.175-184.
  • 9Folkman J,Browder T,Pamblad J.Angiogenesis research: gudieline for translation to clinical application [ J ].Thromb Haemost.2001,86(1) :23 -23.
  • 10Risinger JI, Maxwell GL, Berchunk A, et al. Promoter hy- permethylation as an epigenetic component in Type I and Type II endometrial cancers [ J ]. Ann NY Acad Sci, 2003 (983) :208 -212.

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部